| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438390A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 07/21/2004 | EP1438341A1 Antibody stimulating il-1ra production |
| 07/21/2004 | EP1438340A2 Antibodies against kdr, their production and uses |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438330A2 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438071A1 Therapies for treating respiratory diseases |
| 07/21/2004 | EP1438069A1 Enzyme inhibitors for inactivating allergens |
| 07/21/2004 | EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438057A2 Pine cone extracts and uses thereof |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438051A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438040A1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1223958A4 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514828A Pyrazole derivatives for treating HIV |
| 07/21/2004 | CN1514822A Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 07/21/2004 | CN1514735A Ophthalmic composition comprising hyaluronic acid |
| 07/21/2004 | CN1514731A Extracts of piper betle leaves as immunomodulator |
| 07/21/2004 | CN1514723A Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 07/21/2004 | CN1513993A Coding gene sequence of chinese genom cDNA library interleukin 21 and its amino acid sequence of protein |
| 07/21/2004 | CN1513973A Fatly phospho embrella Pa-I.H bacterial strain and method of culturing fatty phospho embrella and medicine made from its active component |
| 07/21/2004 | CN1513881A Lucid ganoderma spore powder polysaccharide, production method and use |
| 07/21/2004 | CN1513862A Preparation process of plantago fotal glycocide and its application in medicine |
| 07/21/2004 | CN1513558A Anti irritability Specificity Igy and its preparation |
| 07/21/2004 | CN1513523A Chinese medicinal composition for enhancing immune function and preventing and treating homogus rheumatism hyperrosteogeny |
| 07/21/2004 | CN1513497A Immunity regulation medicine composition, and its prepn. method |
| 07/21/2004 | CN1513481A Method for preparing non-specific immunity activator |
| 07/21/2004 | CN1513469A Regulatary factor T for cell growth, and its prepn. method |
| 07/21/2004 | CN1513439A Slow release medicine of pseudo-ephedrine hydrochloride |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158265C Quinoline ketone derivant and antianaphylaction using same as active substance |
| 07/21/2004 | CN1158261C Antivirals |
| 07/21/2004 | CN1158105C Chinese medicine for making body stronger and delayinbg senility and its preparing process |
| 07/21/2004 | CN1158088C Extract of subprostrate sophora its extracting process and its application |
| 07/21/2004 | CN1158083C Nucleic acid oral liquid for animals and its preparing process |
| 07/21/2004 | CN1158074C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/20/2004 | US6765096 Antiallergic agent, immunosuppressant |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/15/2004 | WO2004058974A1 A method of drug screening to select agonists or antagonists of g protein coupled receptors (gpcr). |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058791A2 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/15/2004 | WO2004058788A1 Lipid a analogues having glucose as the right sugar |
| 07/15/2004 | WO2004058772A1 Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same |
| 07/15/2004 | WO2004058770A1 Triptolide derivatives and their use |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058764A1 4-phenyl-pyrimido [4,5-b] indole derivatives |
| 07/15/2004 | WO2004058753A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058742A1 Benzocycloheptapyridine compounds |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058731A1 Benzamide inhibitors of the p2x7 receptor |
| 07/15/2004 | WO2004058729A1 New pyridazin-3(2h)-one derivatives |
| 07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058298A1 Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
| 07/15/2004 | WO2004058295A1 Remedy for pemphigoid |
| 07/15/2004 | WO2004058276A1 Histamine release inhibitor |
| 07/15/2004 | WO2004058159A2 Branched immunomodulatory compounds and methods of using the same |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004041827A3 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α] IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE AND THEIR USE AS INHIBITORS UPON THE INTERACTION OF CAMS AND LEUKO INTEGRINS |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | WO2004031129A3 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 07/15/2004 | WO2004028463A3 Methods and compositions for the treatment of lupus using clofarabine |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
| 07/15/2004 | WO2003099226A3 Antibody peg positional isomers, compositions comprising same, and use thereof |